Radioactive drug trial offers new hope for advanced cancer patients
NCT ID NCT06925581
Summary
This early-stage trial is testing a new radioactive drug called HRS-6768 in patients with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe and effective dose and to see how the drug moves through and affects the body. Researchers will also gather early signs of whether the drug can help control tumor growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Gaobo Hospital
RECRUITINGBeijing, Beijing Municipality, 102206, China
Contact
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.